SaNOtize, an OurCrowd portfolio company, has shown to be 99% effective against COVID-19 in a phase three trial, according to a note distributed by OurCrowd. Simultaneously, the treatment has received regulatory approval in India. OurCrowd has participated in the funding of the firm providing access to individual investors.

Read more here.